Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rowe

Showing results (751-760 of 1,408) with videos related to

Pageof 141
Sort By:
Professional Case Management|October 4, 2019
Time Contribution of Social Workers in Care Management: Value for Older AdultsJeannine M Rowe, Victoria M Rizzo, Suk-Young Kang, et al.
The American Journal of Cardiology|March 7, 2001
Impact of early percutaneous coronary intervention on short- and long-term outcomes in patients with cardiogenic shock after acute myocardial infarctionA E Ajani, P Maruff, R Warren, et al.
International Journal of Epidemiology|June 1, 1996
Child mortality following standard, medium or high titre measles immunization in West AfricaK M Knudsen, P Aaby, H Whittle, et al.
Journal of Virology|December 1, 1992
The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycleA L Lear, M Rowe, M G Kurilla, et al.
International Journal of Cancer|May 15, 1981
Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell lineA B Rickinson, D J Moss, D J Allen, et al.
Cancer Genetics and Cytogenetics|May 1, 1988
Translocation t(6;9)(p23;q34) in acute nonlymphocytic leukemia. Two new patients without increased bone marrow basophilsY S Fan, S N Jani Sait, A Raza, et al.
Frontiers in Immunology|August 6, 2019
Influences of Vitamin A on Vaccine Immunogenicity and EfficacyRhiannon R Penkert, Hannah M Rowe, Sherri L Surman, et al.
Cell|June 28, 1991
Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell deathS Henderson, M Rowe, C Gregory, et al.
The Journal of Pathology|December 1, 1991
Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cellsG Pallesen, S J Hamilton-Dutoit, M Rowe, et al.
American Journal of Hematology|February 21, 2013
Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab eraIrit Avivi, Ariel Zilberlicht, Eldad J Dann, et al.
Pageof 141

Showing results (751-760 of 1,408) with videos related to

Sort By:
Pageof 141
Professional Case Management|October 4, 2019
Time Contribution of Social Workers in Care Management: Value for Older AdultsJeannine M Rowe, Victoria M Rizzo, Suk-Young Kang, et al.
The American Journal of Cardiology|March 7, 2001
Impact of early percutaneous coronary intervention on short- and long-term outcomes in patients with cardiogenic shock after acute myocardial infarctionA E Ajani, P Maruff, R Warren, et al.
International Journal of Epidemiology|June 1, 1996
Child mortality following standard, medium or high titre measles immunization in West AfricaK M Knudsen, P Aaby, H Whittle, et al.
Journal of Virology|December 1, 1992
The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycleA L Lear, M Rowe, M G Kurilla, et al.
International Journal of Cancer|May 15, 1981
Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell lineA B Rickinson, D J Moss, D J Allen, et al.
Cancer Genetics and Cytogenetics|May 1, 1988
Translocation t(6;9)(p23;q34) in acute nonlymphocytic leukemia. Two new patients without increased bone marrow basophilsY S Fan, S N Jani Sait, A Raza, et al.
Frontiers in Immunology|August 6, 2019
Influences of Vitamin A on Vaccine Immunogenicity and EfficacyRhiannon R Penkert, Hannah M Rowe, Sherri L Surman, et al.
Cell|June 28, 1991
Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell deathS Henderson, M Rowe, C Gregory, et al.
The Journal of Pathology|December 1, 1991
Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cellsG Pallesen, S J Hamilton-Dutoit, M Rowe, et al.
American Journal of Hematology|February 21, 2013
Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab eraIrit Avivi, Ariel Zilberlicht, Eldad J Dann, et al.
Pageof 141